Currently, chronic liver inflammation is knowledgeably considered to be the leading cause of NASH,10 and the NF-κB/TNFα signaling pathway is an important inflammatory signaling pathway involved in the development of chronic inflammation in NAFLD.11 Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.